We could not find any results for:
Make sure your spelling is correct or try broadening your search.
JanOne Inc focuses on reducing opioid addiction by finding treatments for conditions accompanied by pain and bringing to market drugs and therapies with nonaddictive pain-relieving properties. The company operates in three operating segments, namely Biotechnology, Recycling, and Technology. It deriv... JanOne Inc focuses on reducing opioid addiction by finding treatments for conditions accompanied by pain and bringing to market drugs and therapies with nonaddictive pain-relieving properties. The company operates in three operating segments, namely Biotechnology, Recycling, and Technology. It derives its majority of revenue from the Recycling segment that is primarily engaged in the recycling of appliances throughout the United States and Canada. Show more
JanOne Regains Compliance with Nasdaq's Listing Requirements PR Newswire LAS VEGAS, March 15, 2024 LAS VEGAS, March 15, 2024 /PRNewswire/ -- JanOne (Nasdaq: JAN), the biopharmaceutical company...
0000862861false00008628612024-02-232024-02-23UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_______________FORM 8-K_______________CURRENT REPORTPURSUANT TO SECTION 13 OR...
0000862861true00008628612024-02-082024-02-08UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_______________FORM 8-K/A_______________CURRENT REPORTPURSUANT TO SECTION 13 OR...
0000862861false00008628612024-02-082024-02-08UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_______________FORM 8-K_______________CURRENT REPORTPURSUANT TO SECTION 13 OR...
0000862861false00008628612024-01-122024-01-12UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_______________FORM 8-K_______________CURRENT REPORTPURSUANT TO SECTION 13 OR...
0000862861FALSE00008628612023-10-092023-10-09UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_______________FORM 8-K_______________CURRENT REPORTPURSUANT TO SECTION 13 OR...
0000862861true00008628612023-08-182023-08-18UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C. 20549_______________FORM 8-K/A_______________CURRENT REPORTPURSUANT TO SECTION 13 OR...
JanOne to Present at the Dawson James 8th Annual Investment Conference PR Newswire LAS VEGAS, Sept. 21, 2023 Chief Medical Officer Dr. Amol Soin will explain innovative approaches to pain...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 1.93798449612 | 2.58 | 2.848 | 2.3 | 121324 | 2.58592737 | CS |
4 | 1.6 | 155.339805825 | 1.03 | 3.2 | 0.96 | 354538 | 2.31685668 | CS |
12 | 2.0454 | 349.880260007 | 0.5846 | 3.2 | 0.4997 | 288766 | 1.49377015 | CS |
26 | 2.21 | 526.19047619 | 0.42 | 3.2 | 0.2204 | 755517 | 0.68132138 | CS |
52 | 1.45 | 122.881355932 | 1.18 | 3.2 | 0.2204 | 449215 | 0.68594404 | CS |
156 | -5.24 | -66.581956798 | 7.87 | 12.28 | 0.2204 | 478126 | 3.31047703 | CS |
260 | 2.15 | 447.916666667 | 0.48 | 31.83 | 0.2204 | 435269 | 4.22942624 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions